We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Ubiquitin–Proteasome System as a Potential Drug Target for Malaria

    The ubiquitin–proteasome system is an essential protein degradation machinery responsible for maintaining cellular protein homeostasis. It is a...
    Chapter 2024
  2. Zonisamide attenuates pressure overload-induced myocardial hypertrophy in mice through proteasome inhibition

    Myocardial hypertrophy is a pathological thickening of the myocardium which ultimately results in heart failure. We previously reported that...

    Qian Wu, Wan-jie Liu, ... **-yong Yu in Acta Pharmacologica Sinica
    Article 14 December 2023
  3. Proteasome-Associated Syndromes: Updates on Genetics, Clinical Manifestations, Pathogenesis, and Treatment

    The ubiquitin–proteasome system (UPS) has a critical role in post-translational protein modification that is essential for the maintenance of all...

    Jiahui Zhang, Panfeng Tao, ... Qing Zhou in Journal of Clinical Immunology
    Article 05 April 2024
  4. The Ubiquitin–Proteasome System and Cerebellar Developmental Disease

    A variety of developmental diseases of the cerebellum are associated with the dysregulation of proteins regulated by the ubiquitin–proteasome system...
    Chapter 2023
  5. Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin–Proteasome System Activation

    Aggregation of α-synuclein (α-syn) and α-syn cytotoxicity are hallmarks of sporadic and familial Parkinson’s disease (PD). Nuclear factor...

    Baojian Guo, Chengyou Zheng, ... Yuqiang Wang in NeuroMolecular Medicine
    Article 03 April 2024
  6. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach

    Relevance

    The proteasome is a crucial mechanism that regulates protein fate and eliminates misfolded proteins, playing a significant role in cellular...

    **gru Yang, Serge Yannick Ouedraogo, ... **anquan Zhan in EPMA Journal
    Article 04 March 2024
  7. Dysregulated proteasome activity and steroid hormone biosynthesis are associated with mortality among patients with acute COVID-19

    The persistence of coronavirus disease 2019 (COVID-19)-related hospitalization severely threatens medical systems worldwide and has increased the...

    Fengjiao Liu, Huqin Yang, ... Jieqiong Li in Journal of Translational Medicine
    Article Open access 04 July 2024
  8. Interplay between proteasome function and inflammatory responses in e-cig vapor condensate-challenged lung epithelial cells

    Exposure to cigarettes and other nicotine-based products results in persistent inflammation in the lung. In recent years, electronic cigarettes...

    R. Begum, S. Thota, S. Batra in Archives of Toxicology
    Article 22 June 2023
  9. Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson’s disease

    Parkinson’s disease (PD) is one of the most common and complex Neurodegeneration, with an inherited metabolic disorder. Fibroblast growth factor 21...

    Yufei Shen, Zhuoying Zhu, ... Baorong Zhang in Experimental Brain Research
    Article Open access 01 November 2023
  10. Inhibition of the Proteasome Regulator PA28 Aggravates Oxidized Protein Overload in the Diabetic Rat Brain

    Oxidized protein overloading caused by diabetes is one accelerating pathological pathway in diabetic encephalopathy development. To determine whether...

    Dong-gui Wu, Yu-na Wang, ... Bei Zhao in Cellular and Molecular Neurobiology
    Article 30 January 2023
  11. Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes

    Background

    Activation of CD28 on multiple myeloma (MM) plasma cells, by binding to CD80 and CD86 on dendritic cells, decreases proteasome subunit...

    Patrizia Leone, Eleonora Malerba, ... Vito Racanelli in Biomarker Research
    Article Open access 23 April 2024
  12. Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model

    Background

    Loss of P-glycoprotein (P-gp) at the blood–brain barrier contributes to amyloid-β (Aβ) brain accumulation in Alzheimer’s disease (AD)....

    Milica Vulin, Yu Zhong, ... Anika M. S. Hartz in Fluids and Barriers of the CNS
    Article Open access 06 October 2023
  13. Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation

    With the development and approval of new proteasome inhibitors, proteasome inhibition is increasingly recognized in cancer therapy. Besides...

    Ayse Tarbin Jannuzzi, Nalan Sümeyra Korkmaz, ... Buket Alpertunga in Cardiovascular Toxicology
    Article 21 February 2023
  14. The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease

    Parkinson’s disease (PD) is the most common neurodegenerative movement disorder. There are no available therapeutics that slow or halt the...

    Kumar Suresh, Michael Mattern, ... Tauseef R. Butt in NeuroMolecular Medicine
    Article 05 February 2023
  15. The Role of Ubiquitin–Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease

    Parkinson's disease (PD) is a common neurodegenerative disease that is mainly in middle-aged people and elderly people, and the pathogenesis of PD is...

    Yu Liang, Guangshang Zhong, ... Changqing Liu in NeuroMolecular Medicine
    Article 12 September 2023
  16. Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets

    Intratumoral heterogeneity impacts the success or failure of anti-cancer therapies. Here, we investigated the evolution and mechanistic heterogeneity...

    Lukas Beumers, Efstathios-Iason Vlachavas, ... Stefan Wiemann in npj Breast Cancer
    Article Open access 02 December 2023
  17. Effects of exercise, metformin, and combination treatments on type 2 diabetic mellitus-induced muscle atrophy in db/db mice: Crosstalk between autophagy and the proteasome

    Both exercise and metformin are common effective clinical treatments of type 2 diabetic mellitus. This study investigated the functional role of...

    Mengqi **ang, **nmeng Yuan, ... Jiao Lu in Journal of Physiology and Biochemistry
    Article 19 December 2023
  18. MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis

    Background

    Proteasome inhibitors (PIs) are one of the most important classes of drugs for the treatment of multiple myeloma (MM). However, almost all...

    **aobin Wang, Yingqing Shi, ... Huihan Wang in Journal of Experimental & Clinical Cancer Research
    Article Open access 05 March 2024
  19. Interactions Between the Ubiquitin–Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence

    Neurodegenerative disorders are chronic brain diseases that affect humans worldwide. Although many different factors are thought to be involved in...

    Luis Angel Monsalvo-Maraver, Enid A. Ovalle-Noguez, ... Karen Rentería-Pérez in Neurotoxicity Research
    Article Open access 23 February 2024
  20. Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors

    Background

    Hepatocellular carcinoma (HCC) remains difficult to treat due to limited effective treatment options. While the proteasome inhibitor...

    Jhin Jieh Lim, Lissa Hooi, ... Edward K.-H. Chow in Journal of Experimental & Clinical Cancer Research
    Article Open access 15 August 2022
Did you find what you were looking for? Share feedback.